Eli Lilly and Company: all 2,262 studies
Page 3 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- A Study of the Effect of Food on Pirtobrutinib (LOXO-305) in Healthy ParticipantsCompletedNCT06180980Phase 1Results posted
- A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Different Formulations of Midazolam in Healthy ParticipantsCompletedNCT06180967Phase 1Results posted
- A Study of Carbon-14-Labelled [14C] LOXO-305 (Pirtobrutinib) in Healthy Male ParticipantsCompletedNCT06180954Phase 1Results posted
- A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT06176768Phase 2Results posted
- A Study of the Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Substrate) in Healthy ParticipantsCompletedNCT06165146Phase 1Results posted
- A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or OverweightCompletedNCT06124807Phase 2Results posted
- A Study of LY3872386 in Healthy Participants and Participants With Atopic DermatitisTerminatedNCT06119529Phase 1Results posted
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 InhibitorCompletedNCT06109311Phase 3Results posted
- A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy ParticipantsCompletedNCT06092931Phase 1Results posted
- A Phase I Study of LY3502970 in Healthy ParticipantsCompletedNCT06085482Phase 1Results posted
- A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic PainCompletedNCT06074562Phase 2Results posted
- A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With MetforminCompletedNCT06045221Phase 3Results posted
- A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related ComorbiditiesCompletedNCT06023095Phase 1Results posted
- A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 DiabetesCompletedNCT06010004Phase 3Results posted
- A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT06007651Phase 1Results posted
- A Drug-Drug Interaction Study to Assess the Pharmacokinetics of DC-806 When Orally Administered Alone, When Coadministered With Itraconazole, and When Coadministered With Carbamazepine in Healthy Adult ParticipantsCompletedNCT05994807Phase 1Results posted
- A Study of Tirzepatide (LY3298176) in Healthy Lactating FemalesCompletedNCT05978713Phase 1Results posted
- A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise AloneCompletedNCT05971940Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)CompletedNCT05963022Phase 3Results posted
- A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesCompletedNCT05936151Phase 2Results posted
- A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.CompletedNCT05936138Phase 1Results posted
- A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity DiseaseCompletedNCT05931380Phase 3Results posted
- A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic DermatitisTerminatedNCT05911841Phase 2Results posted
- A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy ParticipantsCompletedNCT05906836Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque PsoriasisCompletedNCT05896527Phase 2Results posted
- A Study of LY8888AX in Participants Using a Connected Insulin Management PlatformCompletedNCT05893797Not applicableResults posted
- A Study of LY3502970 in Participants With Impaired and Normal Liver FunctionCompletedNCT05882032Phase 1Results posted
- A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 DiabetesCompletedNCT05872620Phase 3Results posted
- BPL-003 Efficacy and Safety in Treatment Resistant DepressionCompletedNCT05870540Phase 2Results posted
- A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related ComorbiditiesActive, not recruitingNCT05869903Phase 3Results posted
- A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in IndiaCompletedNCT05855967Phase 4Results posted
- A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese ParticipantsCompletedNCT05841238Phase 1Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related ComorbiditiesCompletedNCT05822830Phase 3Results posted
- A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection DevicesCompletedNCT05810597Phase 1Results posted
- A Multiple-Dose Study of LY3493269 in Healthy ParticipantsTerminatedNCT05794243Phase 1Results posted
- A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT05767021Phase 3Results posted
- A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)Active, not recruitingNCT05738486Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)CompletedNCT05706506Phase 4Results posted
- A Study of Tirzepatide (LY3298176) in Pediatric Participants With ObesityCompletedNCT05696847Phase 1Results posted
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 DiabetesCompletedNCT05691712Phase 3Results posted
- An Open-Label, Single Dose Study in Patients With Alcohol Use DisorderCompletedNCT05674929Phase 2Results posted
- A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)CompletedNCT05662332Phase 3Results posted
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in IndiaCompletedNCT05659537Phase 4Results posted
- A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy ParticipantsCompletedNCT05644353Phase 1Results posted
- A Study of Absorption, Metabolism, Excretion, and Absolute Bioavailability of Carbon-14-Labelled [14C] Selpercatinib (LY3527723) in Healthy Male ParticipantsCompletedNCT05630287Phase 1Results posted
- A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy ParticipantsCompletedNCT05630274Phase 1Results posted
- A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back PainCompletedNCT05630196Phase 2Results posted
- A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05).CompletedNCT05620576Phase 2Results posted
- A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis PainCompletedNCT05620563Phase 2Results posted
- Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or ObeseCompletedNCT05616013Phase 2Results posted
- A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UCCompletedNCT05611671Phase 2Results posted
- A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)TerminatedNCT05592275Phase 2Results posted
- A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy ParticipantsCompletedNCT05573230Phase 1Results posted
- A Study of Donanemab (LY3002813) in Healthy ParticipantsCompletedNCT05567159Phase 1Results posted
- A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]CompletedNCT05565742Phase 2Results posted
- A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)CompletedNCT05564039Phase 4Results posted
- A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular EventsCompletedNCT05563246Phase 2Results posted
- A Study of Donanemab (LY3002813) in Healthy Chinese ParticipantsCompletedNCT05533411Phase 1Results posted
- A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid ArthritisTerminatedNCT05516758Phase 2Results posted
- A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy ParticipantsCompletedNCT05515601Phase 1Results posted
- A Study of Imlunestrant (LY3484356) in Healthy WomenCompletedNCT05509816Phase 1Results posted
- A Study of LY3844583 in Healthy Participants and Participants With Atopic DermatitisTerminatedNCT05486208Phase 1Results posted
- A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy ParticipantsCompletedNCT05469126Phase 1Results posted
- A Study of Effects of Selpercatinib (LY3527723) on Repaglinide in Healthy ParticipantsCompletedNCT05469113Phase 1Results posted
- A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal FunctionCompletedNCT05469100Phase 1Results posted
- A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy ParticipantsCompletedNCT05468164Phase 1Results posted
- A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection TherapyCompletedNCT05463744Phase 3Results posted
- A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily InjectionsCompletedNCT05462756Phase 3Results posted
- A Study of Imlunestrant (LY3484356) in Female Healthy ParticipantsCompletedNCT05444556Phase 1Results posted
- CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's SarcomaActive, not recruitingNCT05440786Phase 2Results posted
- A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver FunctionCompletedNCT05440344Phase 1Results posted
- A Study of Effects of Selpercatinib in Hepatically Impaired Participants and Healthy ParticipantsCompletedNCT05436912Phase 1Results posted
- A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 DiabetesActive, not recruitingNCT05433584Phase 4Results posted
- Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep ApneaCompletedNCT05412004Phase 3Results posted
- A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of ColorCompletedNCT05372419Phase 3Results posted
- A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With DupilumabCompletedNCT05369403Phase 3Results posted
- A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First TimeCompletedNCT05362058Phase 3Results posted
- A Study of Two Different Formulations of LY3502970 in Healthy ParticipantsCompletedNCT05341089Phase 1Results posted
- A Study of Selpercatinib (LY3527723) in Healthy ParticipantsCompletedNCT05338515Phase 1Results posted
- Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy ParticipantsCompletedNCT05338502Phase 1Results posted
- A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy ParticipantsCompletedNCT05338489Phase 1Results posted
- A Study of Effects of Selpercatinib (LY3527723) on Midazolam in Healthy ParticipantsCompletedNCT05338476Phase 1Results posted
- A Study of the Effect of Food on Selpercatinib (LY3527723) in Healthy ParticipantsCompletedNCT05324124Phase 1Results posted
- A Study of LY3502970 in Healthy Overweight and Obese ParticipantsCompletedNCT05313802Phase 1Results posted
- A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UCCompletedNCT05291689Phase 2Results posted
- A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)Active, not recruitingNCT05288166Phase 3Results posted
- A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal InsulinCompletedNCT05275400Phase 3Results posted
- A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 DiabetesCompletedNCT05262387Phase 1Results posted
- A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or BothCompletedNCT05260021Phase 3Results posted
- A Study of LY3561774 in Participants With Mixed DyslipidemiaCompletedNCT05256654Phase 2Results posted
- Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic PainCompletedNCT05177094Phase 2Results posted
- A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastatin in Healthy ParticipantsCompletedNCT05176314Phase 1Results posted
- Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast CancerActive, not recruitingNCT05169567Phase 3Results posted
- A Relative Bioavailability Study of Selpercatinib (LY3527723) in Healthy ParticipantsCompletedNCT05136404Phase 1Results posted
- Study of the Effect of Food and a Proton Pump Inhibitor (PPI; Omeprazole) on LOXO-305 in Healthy ParticipantsCompletedNCT05134350Phase 1Results posted
- Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy ParticipantsCompletedNCT05134337Phase 1Results posted
- A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic MigraineCompletedNCT05127486Phase 4Results posted
- A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus ErythematosusTerminatedNCT05123586Phase 2Results posted
- A Multiple-Dose Study of LY3502970 in Healthy ParticipantsCompletedNCT05110794Phase 1Results posted
- A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)CompletedNCT05108922Phase 3Results posted